Connexion Media awarded gold status as Microsoft Partner


Published 21-FEB-2017 13:05 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Connexion Media (ASX:CXZ) has been awarded Gold Status Partner of Microsoft’s go-to market services, an endorsement of its position in the ‘connected car’ market.

More specifically the award recognises the group’s unique and innovative vehicle telematics solution and the company’s leading position in connected car SaaS sales globally.

CXZ specialises in developing and commercialising smart car software apps and services for internet-connected vehicles and mobile devices. The Company is based in Australia, with offices in Cambridge and Detroit.

Other high profile brands that have been awarded this elite status are Citrix, Docusign and HP. This is a significant development for CXZ as it positions the group to co-sell with Microsoft, leveraging off the tens of thousands of field sellers and hundreds of thousands of channel partners that are part of the network.

Although, how many of these partnerships prove successful remains to be seen and thus investors considering CXZ for their portfolio, should seek professional financial advice.

Importantly, global automakers and vehicle fleet managers are part of this network which should position CXZ to generate original equipment manufacturer (OEM) sales and assist the company in establishing relationships with fleet management groups.

Microsoft itself continues to build momentum through partnerships with a number of automakers, including Renault-Nissen, Volvo and BMW

CXZ is an existing customer of Microsoft’s cloud services platform, Azure, which it uses to power its telematics solutions, including General Motors Commercial Link service.

Innovative products that have gained global recognition

CXZ has two core products in commercialisation, Flex and miRoamer. Flex is a smart car solution that can manage an entire fleet of vehicles from a mobile phone or computer, delivering cost efficiencies through reduced maintenance costs.

CXZ has established a strong record of forging relationships with technology partners and end users while ensuring that it leads the way in innovative technology. The group’s progress since listing on the ASX in August 2014 can be seen below.

Flex is able to track a range of real time and historical data including vehicle locations, distance travelled, fuel consumption, battery life, engine performance and absolute and average speeds travelled.

miRoamer is a next generation internet radio product that allows users to pick up radio stations from broad geographies, including international stations. It is a market leader in radio technology, delivering a superior understanding of the technical, content and marketing demands of radio manufacturers and car makers alike.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free